Building on new insights about nanoparticles, investigators develop a test for early detection of diseases, including different types of cancer
Investigators from Brigham and Women’s Hospital are taking advantage of a unique phenomenon of nanoparticles to develop a test for early detection of different types of diseases, including cancer. Through previous investigations, Morteza Mahmoudi, PhD, now a biomedical investigator in the Department of Anesthesiology, Perioperative and Pain Medicine, and colleagues have shown that biomolecules in the blood of healthy individuals and patients form various corona profiles around nanoparticles. Like dipping a donut hole in powdered sugar, nanoparticles collect a unique coating of proteins from the blood. In a new study published in the Royal Society of Chemistry’s peer-reviewed journal Nanoscale Horizons, Mahmoudi and the team present evidence that these coronas are personalized and precise, with different compositions or patterns in people with cancers. They have developed a sensor array that has been tested on blood samples, both from people diagnosed with five different types of cancer as well as purportedly healthy people who went on to have a cancer diagnosis several years later. The team’s goal is to develop an early detection test that could be used in the clinic to identify those at risk of cancer and other diseases.
“For cancer and many other catastrophic diseases, the earlier you can diagnose, the more likely you can treat and extend survival and attain better quality of life,” said Mahmoudi, the paper’s corresponding author. Mahmoudi is the former director of the nanobio interactions laboratory at Tehran University of Medical Sciences where he began this work in 2014. “The goal here is to develop a strategy to help people get better information about their health. Today, in the clinic, we have ways to measure lipids and predict risk of cardiovascular disease, but limited ways for cancer. If everything goes well, we hope our work will lead to a screening test for the earliest signs of cancer.”
To carry out their investigation, the team combined the concepts of disease-specific protein coronas with sensor array technology. Sensor arrays can identify a wide variety of interacting chemical and biological compounds all at once rather than in isolation. To test blood samples for early patterns of disease, the team developed a sensor array that consisted of three different cross-reactive liposomes — fatty molecules that caused protein coronas to form around them. The team tested samples from five patients, each with a different form of cancer: lung cancer, glioblastoma, meningioma, myeloma, and pancreatic cancer. The team found that the selected pattern of corona composition, through advanced classification techniques detected by the nanoparticle sensor array, provided a unique “fingerprint” for each type of cancer. The team also tested the tool using blood from 15 people who were subsequently diagnosed with brain, lung, and pancreatic cancer up to eight years later, finding that their approach could identify and discriminate the cancers at the very early stages.
Although promising, as with other diagnostic approaches, the team’s preliminary results will need to be validated in a larger number of people to make sure the test not only works but also provides accurate diagnostic information. Mahmoudi and his colleagues are also interested in applying the technology beyond cancer to diagnose other diseases at an early stage.
“The only reason I’m in science is to do something that can help patients,” said Mahmoudi. “When I see predictions about cancer, the number of new cases each year and its global burden, it excites me to think that our multidisciplinary expertise in nanobio interfaces, sensor array, and advanced statistics may offer a way to help. There is so much potential here and we are working to tap into it.”
The Latest on: Sensory nanoparticles
via Google News
The Latest on: Sensory nanoparticles
- SPIE Photonics West goes online in 2021on January 25, 2021 at 7:31 am
The digital forum will offer live plenary talks, on-demand technical presentations and discussions, online networking, and special events.
- Novel Anti-Tubulin Cytotoxic Agents for Breast Canceron January 21, 2021 at 4:00 pm
ABI-007 is a novel formulation of paclitaxel, which incorporates nanoparticle technology to offer greater drug delivery to malignant cells, while reducing the need for premedications. Larotaxel is ...
- Nanosensors Market Demand, Growth Opportunities and Top Key Players Analysis Report 2021 – 2024on January 20, 2021 at 11:38 pm
Jan (AmericaNewsHour) -- As per the latest report published by Variant Market Research, Global Nanosensors Market is expected to reach ...
- Nonviral Vectors for the Delivery of Small Interfering RNAs to the CNSon January 19, 2021 at 4:00 pm
Nonviral nanoparticles represent a good alternative to viral vectors, but transfection efficiency has to be increased to reach levels that would be relevant for therapeutic purposes. Cationic ...
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Canceron January 13, 2021 at 4:00 pm
16%), as well as a higher rate of grade 2 to 4 sensory neuropathy (26% vs. 18%); however, they had a lower rate of grade 3 or 4 neutropenia (72% vs. 83%). The encouraging clinical-trial results ...
- IS THE BRAIN A DIGITAL COMPUTER? RETHINKING A BINARY QUESTIONon January 12, 2021 at 4:00 pm
Is the brain a digital computer? What about your own brain? This article will examine these questions, some possible answers, and what persistent disagreement on the topic might indicate. Along the ...
- New Way To Make Sensors That Detect Toxic Chemicalson March 18, 2019 at 12:25 pm
“The human nose coordinates signals from hundreds of thousands of sensory neurons to identify chemicals ... he washes it in a common solvent called methyl ethyl ketone to free up the nanoparticles. At ...
- Nanoparticles In Baby Formula: Should Parents Be Worried?on May 17, 2016 at 12:58 pm
And they are “nanoparticles” – a family of ultra ... or altering the physical, textural and sensory properties of foods. But because decreasing particle size may also affect product safety ...
- Don't get burned by your sunscreenon May 23, 2013 at 3:02 am
Nanoparticles of titanium dioxide and zinc ... Scent and skin feel: Finally, we have our trained sensory panel evaluate the scent and skin feel of the products.
via Bing News